194 related articles for article (PubMed ID: 35701707)
1. Prognostic value of pre-transplantation total metabolic tumor volume on
Sugio T; Baba S; Mori Y; Yoshimoto G; Kamesaki K; Takashima S; Urata S; Shima T; Miyawaki K; Kikushige Y; Kunisaki Y; Numata A; Takenaka K; Iawasaki H; Miyamoto T; Ishigami K; Akashi K; Kato K
Int J Hematol; 2022 Oct; 116(4):603-611. PubMed ID: 35701707
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant.
Cherng HJ; Xu G; Feng L; Steiner R; Fayad L; Strati P; Nair R; Nastoupil LJ; Lee HJ; Neelapu SS; Flowers CR; Rodriguez M; Wang M; Hagemeister F; Pinnix CC; Ramdial J; Srour S; Nieto Y; Rezvani K; Champlin R; Kebriaei P; Westin J; Macapinlac HA; Shpall E; Ahmed S
Br J Haematol; 2023 Jan; 200(1):35-44. PubMed ID: 36068929
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic significance of (18)F-fluorodeoxyglucose positron emission tomography in patients with diffuse large B cell lymphoma undergoing autologous stem cell transplantation].
Ying ZT; Mi L; Wang XJ; Zhang YW; Yang Z; Song YQ; Wang XP; Zheng W; Lin NJ; Tu MF; Xie Y; Ping LY; Zhang C; Liu WP; Deng LJ; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):382-386. PubMed ID: 29779346
[No Abstract] [Full Text] [Related]
4. Prognostic value of
Ying Z; Mi L; Zhou N; Wang X; Yang Z; Song Y; Wang X; Zheng W; Lin N; Tu M; Xie Y; Ping L; Zhang C; Liu W; Deng L; Zhu J
Chin J Cancer Res; 2019 Feb; 31(1):162-170. PubMed ID: 30996574
[TBL] [Abstract][Full Text] [Related]
5. Post-transplantation Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Lymphoblastic Lymphoma is an Independent Prognostic Factor with an Impact on Progression-Free Survival but not Overall Survival.
Dai N; Liu H; Deng S; Sang S; Wu Y
Technol Cancer Res Treat; 2021; 20():15330338211056478. PubMed ID: 34806464
[No Abstract] [Full Text] [Related]
6. Pretransplantation fluorine-18-deoxyglucose--positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation.
Sauter CS; Lechner L; Scordo M; Zheng J; Devlin SM; Fleming SE; Castro-Malaspina H; Moskowitz CH
Biol Blood Marrow Transplant; 2014 Jun; 20(6):881-4. PubMed ID: 24534109
[TBL] [Abstract][Full Text] [Related]
7. Positron Emission Tomography-Based Assessment of Metabolic Tumor Volume Predicts Survival after Autologous Hematopoietic Cell Transplantation for Hodgkin Lymphoma.
Procházka V; Gawande RS; Cayci Z; Froelich JW; Cao Q; Wilke C; Dusenbery K; Weisdorf DJ; Bachanova V
Biol Blood Marrow Transplant; 2018 Jan; 24(1):64-70. PubMed ID: 28942016
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy.
Georgi TW; Kurch L; Franke GN; Jentzsch M; Schwind S; Perez-Fernandez C; Petermann N; Merz M; Metzeler K; Borte G; Hoffmann S; Herling M; Denecke T; Kluge R; Sabri O; Platzbecker U; Vučinić V
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6131-6138. PubMed ID: 36662305
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis.
Adams HJ; Kwee TC
Ann Hematol; 2016 Apr; 95(5):695-706. PubMed ID: 26931115
[TBL] [Abstract][Full Text] [Related]
10. Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantation.
Eyre TA; Barrington SF; Okosun J; Abamba C; Pearce RM; Lee J; Carpenter B; Crawley CR; Bloor AJC; Gilleece M; Nicholson E; Shah N; Orchard K; Malladi R; Townsend WM
Haematologica; 2023 Mar; 108(3):785-796. PubMed ID: 35586966
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of
Sun N; Qiao W; Xing Y; Wang T; Yang J; Zhao J
Clin Transl Oncol; 2021 Aug; 23(8):1571-1576. PubMed ID: 33449269
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.
Yoon JH; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Cho SG
Hematol Oncol; 2017 Mar; 35(1):17-24. PubMed ID: 25782369
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of 2-Deoxy-2-[
Dai N; Zhou Y; Deng S; Sang S; Wu Y
Contrast Media Mol Imaging; 2021; 2021():5510825. PubMed ID: 33958977
[TBL] [Abstract][Full Text] [Related]
14. Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.
Bouard L; Bodet-Milin C; Bailly C; Guillaume T; Peterlin P; Garnier A; Bourgeois AL; Mahé B; Dubruille V; Blin N; Touzeau C; Gastinne T; Lok A; Bonnet A; Béné MC; Gouill SL; Moreau P; Kraeber-Bodéré F; Chevallier P
Biol Blood Marrow Transplant; 2019 May; 25(5):906-911. PubMed ID: 30481598
[TBL] [Abstract][Full Text] [Related]
15. Surveillance Imaging after Autologous Hematopoietic Cell Transplantation Predicts Survival in Patients with Diffuse Large B Cell Lymphoma.
Savani M; Gencturk M; Shanley R; Cayci Z; Wilke C; Warlick ED; He F; Janakiram M; Weisdorf DJ; Brunstein CG; Bachanova V
Biol Blood Marrow Transplant; 2020 Feb; 26(2):272-277. PubMed ID: 31669174
[TBL] [Abstract][Full Text] [Related]
16. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
17. [Outcomes of 33 patients with anaplastic large cell lymphoma treated after hematopoietic stem cell transplantation].
Lu N; Li XF; Dong YJ; Wang YN; Fu XR; Wu YM; Li YH; Wang MH; Li NN; Ren HY; Wang Z; Zhang MZ; Wu XX; Hu LD; Liu Y; Huang WR
Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):117-122. PubMed ID: 32135627
[No Abstract] [Full Text] [Related]
18. Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors.
Gupta A; Gokarn A; Rajamanickam D; Punatar S; Thippeswamy R; Mathew L; Bagal B; Kannan S; Khattry N
J Cancer Res Ther; 2018; 14(5):926-933. PubMed ID: 30197327
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of [¹⁸F]fluoro-2-deoxy-D-glucose positron emission tomography for clinical outcome in patients with relapsed/refractory diffuse large B-cell lymphoma prior to and after autologous stem cell transplant.
Qiao W; Zhao J; Xing Y; Wang C; Wang T
Leuk Lymphoma; 2014 Feb; 55(2):276-82. PubMed ID: 23617323
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
